Home › J&J buys bowel drug license option from Isis Pharma for $835 million
 

Keywords :   


J&J buys bowel drug license option from Isis Pharma for $835 million

2015-01-06 03:00:04| Food - Topix.net

Johnson & Johnson will pay Isis Pharmaceuticals Inc up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel. Isis Pharmaceuticals said it will receive $35 million in an upfront payment and will be eligible to receive royalties on sales of the drugs.

Tags: million license option drug

Category:Food and Related Products

Latest from this category

All news
»
08.11Up close with the 300 tonne driverless trucks
08.11China is trying to fix its economy. Trump could derail those plans
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
07.11Remnants of Fourteen-E Graphics
07.11Remnants of Fourteen-E Forecast Discussion Number 6
07.11Remnants of Fourteen-E Wind Speed Probabilities Number 6
07.11Remnants of Fourteen-E Public Advisory Number 6
More »